{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T02:06:44Z","timestamp":1785722804697,"version":"3.56.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012331","name":"Agentschap Innoveren en Ondernemen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography A"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.chroma.2020.461808","type":"journal-article","created":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T22:54:21Z","timestamp":1609282461000},"page":"461808","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Middle-up characterization of monoclonal antibodies by online reduction liquid chromatography-mass spectrometry"],"prefix":"10.1016","volume":"1637","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8167-3546","authenticated-orcid":false,"given":"Liesa","family":"Verscheure","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Oosterlynck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Cerdobbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pat","family":"Sandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Lynen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Sandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chroma.2020.461808_bib0001","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.coph.2012.08.001","article-title":"Monoclonal antibody therapeutics: history and future","volume":"12","author":"Buss","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.chroma.2020.461808_bib0002","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijpharm.2011.12.039","article-title":"Therapeutic antibodies: Market considerations, disease targets and bioprocessing","volume":"440","author":"Elvin","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chroma.2020.461808_bib0003","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/nbt.3040","article-title":"Biopharmaceutical benchmarks 2014","volume":"32","author":"Walsh","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.chroma.2020.461808_bib0004","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4161\/19420862.2015.989042","article-title":"The therapeutic monoclonal antibody market","volume":"7","author":"Ecker","year":"2015","journal-title":"MAbs"},{"key":"10.1016\/j.chroma.2020.461808_bib0005","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/nbt.4305","article-title":"Biopharmaceutical benchmarks 2018","volume":"36","author":"Walsh","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.chroma.2020.461808_bib0006","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0140-6736(19)31774-X","article-title":"Antibody\u2013drug conjugates for cancer","volume":"394","author":"Chau","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.chroma.2020.461808_bib0007","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41573-019-0028-1","article-title":"Bispecific antibodies: a mechanistic review of the pipeline","volume":"18","author":"Labrijn","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.chroma.2020.461808_bib0008","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2019.1703531","article-title":"Antibodies to watch in 2020","volume":"12","author":"Kaplon","year":"2020","journal-title":"MAbs"},{"key":"10.1016\/j.chroma.2020.461808_bib0009","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.chroma.2013.11.057","article-title":"Modern chromatographic and mass spectrometric techniques for protein biopharmaceutical characterization","volume":"1335","author":"Sandra","year":"2014","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.chroma.2020.461808_bib0010","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1021\/acs.analchem.5b04561","article-title":"Chromatographic, Electrophoretic, and Mass Spectrometric Methods for the Analytical Characterization of Protein Biopharmaceuticals","volume":"88","author":"Fekete","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2020.461808_bib0011","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1021\/ac3032355","article-title":"Characterization of Therapeutic Antibodies and Related Products","volume":"85","author":"Beck","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2020.461808_bib0012","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/mas.20190","article-title":"Mass spectrometry for structural characterization of therapeutic antibodies","volume":"28","author":"Zhang","year":"2009","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.chroma.2020.461808_bib0013","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jasms.2007.12.006","article-title":"Molecular mass analysis of antibodies by on-line SEC-MS","volume":"19","author":"Brady","year":"2008","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.chroma.2020.461808_bib0014","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/j.jasms.2009.08.015","article-title":"Analysis of reduced monoclonal antibodies using size exclusion chromatography coupled with mass spectrometry","volume":"20","author":"Liu","year":"2009","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.chroma.2020.461808_bib0015","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1021\/ac203346c","article-title":"Native Intact Mass Determination of Antibodies Conjugated with Monomethyl Auristatin E and F at Interchain Cysteine Residues","volume":"84","author":"Valliere-Douglass","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2020.461808_bib0016","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.1021\/ac401455f","article-title":"Nondenaturing Size-Exclusion Chromatography-Mass Spectrometry to Measure Stress-Induced Aggregation in a Complex Mixture of Monoclonal Antibodies","volume":"85","author":"Woodard","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2020.461808_bib0017","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/19420862.2015.1122150","article-title":"Rapid characterization of biotherapeutic proteins by size-exclusion chromatography coupled to native mass spectrometry","volume":"8","author":"Haberger","year":"2016","journal-title":"MAbs"},{"key":"10.1016\/j.chroma.2020.461808_bib0018","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jchromb.2017.09.027","article-title":"Characterization of 30 therapeutic antibodies and related products by size exclusion chromatography: Feasibility assessment for future mass spectrometry hyphenation","volume":"1065\u20131066","author":"Goyon","year":"2017","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.chroma.2020.461808_bib0019","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jchromb.2018.04.010","article-title":"Hyphenation of size exclusion chromatography to native ion mobility mass spectrometry for the analytical characterization of therapeutic antibodies and related products","volume":"1086","author":"Ehkirch","year":"2018","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.chroma.2020.461808_bib0020","first-page":"304","article-title":"Denaturing and Native Size-Exclusion Chromatography Coupled to High-Resolution Mass Spectrometry for Detailed Characterization of Monoclonal Antibodies and Antibody\u2013Drug Conjugates","volume":"32","author":"Sandra","year":"2019","journal-title":"LCGC Eur"},{"key":"10.1016\/j.chroma.2020.461808_bib0021","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jchromb.2017.02.017","article-title":"Charge variants characterization of a monoclonal antibody by ion exchange chromatography coupled on-line to native mass spectrometry: Case study after a long-term storage at +5\u00b0C","volume":"1048","author":"Leblanc","year":"2017","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.chroma.2020.461808_bib0022","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1021\/acs.analchem.7b05241","article-title":"Charge variant analysis of monoclonal antibodies using direct coupled pH gradient cation exchange chromatography to high-resolution native mass spectrometry","volume":"90","author":"F\u00fcssl","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2020.461808_bib0023","doi-asserted-by":"crossref","first-page":"13013","DOI":"10.1021\/acs.analchem.8b03773","article-title":"Ultrasensitive Characterization of Charge Heterogeneity of Therapeutic Monoclonal Antibodies Using Strong Cation Exchange Chromatography Coupled to Native Mass Spectrometry","volume":"90","author":"Yan","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2020.461808_bib0024","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1080\/19420862.2018.1521131","article-title":"Charge variant native mass spectrometry benefits mass precision and dynamic range of monoclonal antibody intact mass analysis","volume":"10","author":"Bailey","year":"2018","journal-title":"MAbs"},{"key":"10.1016\/j.chroma.2020.461808_bib0025","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/19420862.2018.1531664","article-title":"Comprehensive characterisation of the heterogeneity of adalimumab via charge variant analysis hyphenated on-line to native high resolution Orbitrap mass spectrometry","volume":"11","author":"F\u00fcssl","year":"2019","journal-title":"MAbs"},{"key":"10.1016\/j.chroma.2020.461808_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2019.121814","article-title":"A generic method for intact and subunit level characterization of mAb charge variants by native mass spectrometry","volume":"1133","author":"Leblanc","year":"2019","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.chroma.2020.461808_bib0027","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2020.1763762","article-title":"Hyphenation of strong cation exchange chromatography to native mass spectrometry for high throughput online characterization of charge heterogeneity of therapeutic monoclonal antibodies","volume":"12","author":"Ma","year":"2020","journal-title":"MAbs"},{"key":"10.1016\/j.chroma.2020.461808_bib0028","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2020.1739825","article-title":"Characterization of therapeutic proteins by cation exchange chromatography-mass spectrometry and top-down analysis","volume":"12","author":"Shi","year":"2020","journal-title":"MAbs"},{"key":"10.1016\/j.chroma.2020.461808_bib0029","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1002\/jps.20966","article-title":"The LC\/MS Analysis of Glycation of IGG Molecules in Sucrose Containing Formulations","volume":"96","author":"Gadgil","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.chroma.2020.461808_bib0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.chroma.2007.06.063","article-title":"Analysis of post-translational modifications in recombinant monoclonal antibody IgG1 by reversed-phase liquid chromatography\/mass spectrometry","volume":"1164","author":"Yan","year":"2007","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.chroma.2020.461808_bib0031","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jchromb.2016.05.004","article-title":"Discovery and characterization of antibody variants using mass spectrometry-based comparative analysis for biosimilar candidates of monoclonal antibody drugs","volume":"1025","author":"Li","year":"2016","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.chroma.2020.461808_bib0032","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jchromb.2017.06.036","article-title":"Protocols for the analytical characterization of therapeutic monoclonal antibodies. II \u2013 Enzymatic and chemical sample preparation","volume":"1060","author":"Bobaly","year":"2017","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.chroma.2020.461808_bib0033","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jchromb.2018.05.010","article-title":"Characterization of recombinant monoclonal IgG2 antibodies using LC-MS and limited Lys-C digestion","volume":"1092","author":"Nowak","year":"2018","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.chroma.2020.461808_bib0034","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ab.2011.04.030","article-title":"Fast analysis of recombinant monoclonal antibodies using IdeS proteolytic digestion and electrospray mass spectrometry","volume":"415","author":"Chevreux","year":"2011","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.chroma.2020.461808_bib0035","doi-asserted-by":"crossref","first-page":"641","DOI":"10.4161\/mabs.25302","article-title":"Rapid Fc glycosylation analysis of Fc fusions with IdeS and liquid chromatography mass spectrometry","volume":"5","author":"Lynaugh","year":"2013","journal-title":"MAbs"},{"key":"10.1016\/j.chroma.2020.461808_bib0036","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4161\/mabs.26773","article-title":"Antibody-drug conjugate model fast characterization by LC-MS following IdeS proteolytic digestion","volume":"6","author":"Wagner-Rousset","year":"2014","journal-title":"MAbs"},{"key":"10.1016\/j.chroma.2020.461808_bib0037","doi-asserted-by":"crossref","first-page":"8307","DOI":"10.1021\/acs.analchem.5b01578","article-title":"Direct Identification of Rituximab Main Isoforms and Subunit Analysis by Online Selective Comprehensive Two-Dimensional Liquid Chromatography\u2013Mass Spectrometry","volume":"87","author":"Stoll","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2020.461808_bib0038","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ab.2015.06.001","article-title":"A rapid approach for characterization of thiol-conjugated antibody\u2013drug conjugates and calculation of drug\u2013antibody ratio by liquid chromatography mass spectrometry","volume":"485","author":"Firth","year":"2015","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.chroma.2020.461808_bib0039","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.chroma.2016.04.056","article-title":"Potential of hydrophilic interaction chromatography for the analytical characterization of protein biopharmaceuticals","volume":"1448","author":"Periat","year":"2016","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.chroma.2020.461808_bib0040","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1039\/C6AN00071A","article-title":"Rapid and improved characterization of therapeutic antibodies and antibody related products using IdeS digestion and subunit analysis","volume":"141","author":"Sj\u00f6gren","year":"2016","journal-title":"Analyst"},{"key":"10.1016\/j.chroma.2020.461808_bib0041","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1021\/acs.analchem.6b04726","article-title":"Hydrophilic Interaction Chromatography Hyphenated with Mass Spectrometry: A Powerful Analytical Tool for the Comparison of Originator and Biosimilar Therapeutic Monoclonal Antibodies at the Middle-up Level of Analysis","volume":"89","author":"D'Atri","year":"2017","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2020.461808_bib0042","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jchromb.2018.02.026","article-title":"Characterization of an antibody-drug conjugate by hydrophilic interaction chromatography coupled to mass spectrometry","volume":"1080","author":"D'Atri","year":"2018","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.chroma.2020.461808_bib0043","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jchromb.2018.08.013","article-title":"Protocols for the analytical characterization of therapeutic monoclonal antibodies. III \u2013 Denaturing chromatographic techniques hyphenated to mass spectrometry","volume":"1096","author":"D'Atri","year":"2018","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.chroma.2020.461808_bib0044","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jpba.2017.11.046","article-title":"Middle-up analysis of monoclonal antibodies after combined IgdE and IdeS hinge proteolysis: Investigation of free sulfhydryls","volume":"149","author":"Faid","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2020.461808_bib0045","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/s41467-018-04061-7","article-title":"Native mass spectrometry combined with enzymatic dissection unravels glycoform heterogeneity of biopharmaceuticals","volume":"9","author":"Wohlschlager","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chroma.2020.461808_bib0046","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/bioengineering6030062","article-title":"Forced Degradation Testing as Complementary Tool for Biosimilarity Assessment","volume":"6","author":"Dyck","year":"2019","journal-title":"Bioengineering"},{"key":"10.1016\/j.chroma.2020.461808_bib0047","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1007\/s00216-018-1561-1","article-title":"A generic workflow for the characterization of therapeutic monoclonal antibodies\u2014application to daratumumab","volume":"411","author":"Duivelshof","year":"2019","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.chroma.2020.461808_bib0048","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2019.1682403","article-title":"Monitoring glycation levels of a bispecific monoclonal antibody at subunit level by ultrahigh-resolution MALDI FT-ICR mass spectrometry","volume":"12","author":"Gst\u00f6ttner","year":"2020","journal-title":"MAbs"},{"key":"10.1016\/j.chroma.2020.461808_bib0049","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2020.1781743","article-title":"Investigation of monoclonal antibody dimers in a final formulated drug by separation techniques coupled to native mass spectrometry","volume":"12","author":"Rouby","year":"2020","journal-title":"MAbs"},{"key":"10.1016\/j.chroma.2020.461808_bib0050","doi-asserted-by":"crossref","first-page":"8170","DOI":"10.1021\/acs.analchem.0c00282","article-title":"Glycan-Mediated Technology for Obtaining Homogeneous Site-Specific Conjugated Antibody\u2013Drug Conjugates: Synthesis and Analytical Characterization by Using Complementary Middle-up LC\/HRMS Analysis","volume":"92","author":"Duivelshof","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2020.461808_bib0051","series-title":"Antibody-Drug Conjug","first-page":"187","article-title":"Drug Loading and Distribution of ADCs After Reduction or IdeS Digestion and Reduction","author":"Wagner-Rousset","year":"2020"},{"key":"10.1016\/j.chroma.2020.461808_bib0052","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1080\/19420862.2018.1511198","article-title":"A systematic approach for analysis and characterization of mispairing in bispecific antibodies with asymmetric architecture","volume":"10","author":"Wang","year":"2018","journal-title":"MAbs"},{"key":"10.1016\/j.chroma.2020.461808_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113130","article-title":"Automated middle-up approach for the characterization of biotherapeutic products by combining on-line hinge-specific digestion with RPLC-HRMS analysis","volume":"182","author":"Camperi","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2020.461808_bib0054","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1021\/acs.analchem.9b05193","article-title":"Development of a 3D-LC\/MS Workflow for Fast, Automated, and Effective Characterization of Glycosylation Patterns of Biotherapeutic Products","volume":"92","author":"Camperi","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2020.461808_bib0055","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jchromb.2014.04.023","article-title":"Size-exclusion chromatography-mass spectrometry with m-nitrobenzyl alcohol as post-column additive for direct characterization of size variants of monoclonal antibodies","volume":"960","author":"Xu","year":"2014","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.chroma.2020.461808_bib0056","doi-asserted-by":"crossref","first-page":"14896","DOI":"10.1021\/acs.analchem.9b02454","article-title":"Streamlined Characterization of an Antibody\u2013Drug Conjugate by Two-Dimensional and Four-Dimensional Liquid Chromatography\/Mass Spectrometry","volume":"91","author":"Goyon","year":"2019","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2020.461808_bib0057","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1021\/acs.analchem.7b04372","article-title":"Fast and automated characterization of antibody variants with 4D HPLC\/MS","volume":"90","author":"Gst\u00f6ttner","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2020.461808_bib0058","doi-asserted-by":"crossref","first-page":"8506","DOI":"10.1021\/acs.analchem.0c01250","article-title":"Fast and automated characterization of monoclonal antibody minor variants from cell cultures by combined Protein-A and multi-dimensional LC\/MS methodologies","volume":"92","author":"Camperi","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2020.461808_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2019.460740","article-title":"From proof of concept to the routine use of an automated and robust multi-dimensional liquid chromatography mass spectrometry workflow applied for the charge variant characterization of therapeutic antibodies","volume":"1615","author":"Goyon","year":"2020","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.chroma.2020.461808_bib0060","first-page":"10","article-title":"Rapid Online Reduction and Characterization of Protein Modifications Using Fully Automated Two-Dimensional High Perform Liquid Chromatography-Mass Spectrometry","volume":"31","author":"Bathke","year":"2018","journal-title":"LC GC Eur"},{"key":"10.1016\/j.chroma.2020.461808_bib0061","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1002\/jps.21655","article-title":"Succinimide formation at Asn 55 in the complementarity determining region of a recombinant monoclonal antibody IgG1 heavy chain","volume":"98","author":"Yan","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.chroma.2020.461808_bib0062","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ab.2018.11.021","article-title":"Characterization and quantification of succinimide using peptide mapping under low-pH conditions and hydrophobic interaction chromatography","volume":"566","author":"Cao","year":"2019","journal-title":"Anal. Biochem."}],"container-title":["Journal of Chromatography A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967320310827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967320310827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T06:05:01Z","timestamp":1758261901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021967320310827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":62,"alternative-id":["S0021967320310827"],"URL":"https:\/\/doi.org\/10.1016\/j.chroma.2020.461808","relation":{},"ISSN":["0021-9673"],"issn-type":[{"value":"0021-9673","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Middle-up characterization of monoclonal antibodies by online reduction liquid chromatography-mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography A","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chroma.2020.461808","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"461808"}}